Related Experiment Video
Updated: Dec 28, 2025
Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
Published on: May 6, 2014
Nursing Home-Associated Pneumonia, Part II: Etiology and Treatment
1Professor Emeritus, Department of Medicine, Division of Infectious Diseases, Jacobs School of Medicine and Biomedical Science, State University of New York at Buffalo, Buffalo, NY.
Nursing home-associated pneumonia (NHAP) is often not caused by resistant organisms, contrary to previous beliefs. Most NHAP cases can be successfully treated within the nursing home setting, but specific guidelines are needed.
Area of Science:
- Infectious Diseases
- Geriatric Medicine
- Pharmacology
Background:
- Nursing home-associated pneumonia (NHAP) was previously considered similar to community-acquired pneumonia (CAP).
- The introduction of healthcare-associated pneumonia (HCAP) in 2005 included nursing home residents, implying a high risk of multidrug-resistant organisms.
- Recent studies challenge this notion, finding limited evidence of resistant organisms in NHAP.
Purpose of the Study:
- To review the etiology and treatment of nursing home-associated pneumonia (NHAP).
- To discuss current management considerations for NHAP in nursing home residents.
- To highlight the need for specific NHAP diagnostic and treatment guidelines.
Main Methods:
- Narrative review of existing literature on NHAP.
- Analysis of studies investigating the etiology of NHAP.
- Discussion of clinical management strategies for NHAP.
Main Results:
- Sophisticated diagnostic testing revealed limited evidence of multidrug-resistant organisms in NHAP.
- Management considerations include hospitalization decisions, antibiotic therapy (oral/parenteral), regimen switching, and therapy duration.
- Current treatment recommendations are based on limited data, lacking randomized controlled trials.
Conclusions:
- Most nursing home residents with pneumonia can be treated effectively in the nursing home.
- There is an urgent need for evidence-based, specific guidelines for NHAP diagnosis and treatment.
- Current management practices require refinement based on updated etiological understanding.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
07:27Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa
Published on: July 12, 2018
Related Concept Videos
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia III: Complications and Assessment
01:29Pneumonia II: Pathophysiology
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment